Nuvation Bio is trading at $5.87 (-4.01%) in an apparent pullback following the prior session’s 4.09% gain and a recent multi-day rebound.
- No company-specific catalyst is evident in available news to explain the current downward price action.
- The broader market is mixed, with the Nasdaq trading slightly lower, though the index's performance does not fully account for the stock's decline.